• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    MELA Sciences, Inc. (MELA)

    1.21 Up 0.01(0.82%) Nov 27, 12:55PM EST
    ProfileGet Profile for:
    MELA Sciences, Inc.
    50 South Buckhout Street
    Suite 1
    Irvington, NY 10533
    United States - Map
    Phone: 914-591-3783
    Fax: 914-591-3785
    Website: http://www.melasciences.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:32

    Business Summary 

    MELA Sciences, Inc., a medical device company, designs and develops software-driven technology for the early detection of skin cancer to dermatologists in the United States. It offers XTRAC, an ultraviolet light excimer laser system for the treatment of psoriasis, vitiligo, and other skin diseases; and VTRAC Excimer Lamp system for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company also focuses on commercialization of its principal product MelaFind, a non-invasive point-of-care instrument to aid in the detection of melanoma. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MELA Sciences, Inc.

    Key Executives 
    Mr. Jeffrey Francis O'Donnell Sr., 55
    Exec. Chairman, Member of Compensation Committee, Member of Special Transaction Committee and Member of Nominating & Corp. Governance Committee
    Mr. Michael R. Stewart , 58
    Chief Exec. Officer, Pres and Director
    Mr. Robert W. Cook , 59
    Sr. Financial Advisor
    Ms. Christina L. Allgeier , 43
    Chief Financial Officer
    Diana Garcia Redruello MIA,
    Head of Global Marketing & International Bus.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders